To detect whether the association between serum ALB levels and 60-day mortality of AML was present in different subgroups, analyses and interactive analyses were stratified according to the confounders, including age, sex, Glu level, MYO level, and chemotherapy (Fig. 3). The gene discussed is ALB; the disease is acute myeloid leukemia.